Date: 21 Apr 2011
Racial Disparity in Blood Pressure: is Vitamin D a Factor?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Higher prevalence of hypertension among African Americans is a key cause of racial disparity in cardiovascular morbidity and mortality. Explanations for the difference in prevalence are incomplete. Emerging data suggest that low vitamin D levels may contribute.
To assess the contribution of vitamin D to racial disparity in blood pressure.
Adult non-Hispanic Black and White participants from the National Health and Nutrition Examination Survey 2001–2006.
We assessed Black-White differences in systolic blood pressure (SBP) controlling for conventional risk factors, and then additionally, for vitamin D (serum 25[OH]D).
The sample included 1984 and 5156 Black and White participants ages 20 years and older. The mean age-sex adjusted Black-White SBP difference was 5.2 mm Hg. This difference was reduced to 4.0 mm Hg with additional adjustment for socio-demographic characteristics, health status, health care, health behaviors, and biomarkers; adding 25(OH)D reduced the race difference by 26% (95% CI 7–46%) to 2.9 mm Hg. This effect increased to 39% (95% CI 14–65%) when those on antihypertensive medications were excluded. Supplementary analyses that controlled for cardiovascular fitness, percent body fat, physical activity monitoring, skin type and social support yielded consistent results.
In cross-sectional analyses, 25(OH)D explains one quarter of the Black-White disparity in SBP. Randomized controlled trials are required to determine whether vitamin D supplementation could reduce racial disparity in BP.
Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, High Serum Total Choleseterol, and Diabetes: Racial and Ethnic Prevalence Differences in U.S. Adults, 1999–2006. Hyattsville, MD: National Center for Health Statistics, 2010.
Forrester T, Cooper RS, Weatherall D. Emergence of Western diseases in the tropical world: the experience with chronic cardiovascular diseases. Br Med Bull. 1998;54:463–473.PubMed
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238.PubMed
Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000;87:214–220.PubMed
Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metabol. 2005;288:E125–E132.CrossRef
Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Pres Res. 2003;26:27–33.CrossRef
Pilz S, Tomaschitz A, Ritz E. Pieber TR. Medscape. Vitamin D status and arterial hypertension: a systematic review. Nature Rev Cardiol. 2009;6:621–630.
Signorello LB, Williams SM, Zheng W et al. Blood vitamin D levels in relation to genetic estimation of African ancestry. Cancer Epidemiol Biomarkers Prev. 2010.
Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2008;87:136–141.PubMed
Miller WG. Estimating glomerular filtration rate. Clin Chemistry Lab Med. 2009;47:1017–1019.CrossRef
National Health and Nutrition Examination Survey. National Health and Nutrition Examination Survey. Physician examination procedures manual (original 1999, revised 2000). http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/physician_year_3.pdf acccessed 3/18/2011.
Ham SA, Ainsworth BE. Disparities in data on Healthy People 2010 physical activity objectives collected by accelerometry and self-report. Am J Public Health. 2010;100:Suppl-8.
Clogg CC, Petkova E, Haritou A. Statistical methods for comparing regression coefficients between models. Am J Sociol. 1995;100:1261–1293.CrossRef
Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metabol. 2005;90:635–640.CrossRef
Jamerson KA. The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue. J Clin Hypertens. 2004;6:Suppl-10.
Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70–15.PubMed
Hersch J. Profiling the new immigrant Worker: the effects of skin color and height. J Labor Econom. 2008;26:345–386.CrossRef
Hersch J. Skin-Tone effects among African Americans: perceptions and reality. The Am Econom Rev. 2006;96:251–255.CrossRef
Harrison MS, Thomas KM. The hidden prejudice in selection: A research investigation on skin color bias. J Applied Soc Psych. 2009;39:134–168.CrossRef
Fiscella K, Holt K. Racial disparity in hypertension control: The death toll. Ann Fam Med. 2008;6:486–489.CrossRef
Houghton JL, Philbin EF, Strogatz DS, et al. The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. Am J Cardiol. 2002;39:1314–1322.CrossRef
Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metabol. 2009;94:4023–4030.CrossRef
Wilson TW, Hollifield LR, Grim CE. Systolic blood pressure levels in black populations in sub-Sahara Africa, the West Indies, and the United States: a meta-analysis. Hypertension. 1991;18:Suppl-91.
- Racial Disparity in Blood Pressure: is Vitamin D a Factor?
Journal of General Internal Medicine
Volume 26, Issue 10 , pp 1105-1111
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- vitamin D
- blood pressure
- African continental ancestry
- Industry Sectors
- Author Affiliations
- 1. Departments of Family Medicine and Community & Preventive Medicine, University of Rochester School of Medicine, 1381 South Ave, Rochester, NY, 14620, USA
- 2. Department of Family Medicine, University of Rochester School of Medicine, 1381 South Ave, Rochester, NY, 14620, USA
- 3. Center for Healthcare Policy and Research, Department of Pediatrics, University of California at Davis, Sacramento, CA, USA
- 4. Center for Healthcare Policy and Research, Department of Family & Community Medicine, University of California at Davis, Sacramento, CA, USA